INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 31 January 2014
Total net assets |
£197.5m |
NAV per share |
358.0p |
Share price |
306.0p |
Total value of unquoted investments |
£25.6m |
Total number of portfolio companies |
102 |
Top Ten Holdings
Company Name |
% NAV |
Gilead |
7.6 |
Biogen |
6.8 |
Regeneron |
5.5 |
Celgene |
5.2 |
Amgen |
4.8 |
Alexion |
4.1 |
Illumina |
4.0 |
Vertex |
3.5 |
Fluidigm |
2.8 |
Mylan |
2.7 |
|
----------- |
Total |
47.0 |
Trust Characteristics |
% NAV |
Profitable |
54 |
Turning Profitable 2015 |
11 |
Unprofitable |
35 |
|
----------- |
Total |
100 |
Geographical Allocation |
% NAV |
United States & Canada |
90 |
Europe & UK |
10 |
|
----------- |
Total |
100 |
Quoted/Unquoted allocation |
% NAV |
Quoted |
88 |
Unquoted |
12 |
|
----------- |
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
24 FEBRUARY 2014